-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q4 2024.
- Lexaria Bioscience Corp. Net Cash Provided by (Used in) Operating Activities for the quarter ending November 30, 2024 was -$2.73M, a 131% decline year-over-year.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$4.96M, a 15.7% increase from 2023.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$5.88M, a 20.5% decline from 2022.
- Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$4.88M, a 22.3% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)